Impact of frailty on cancer-related fatigue and quality of life in outpatients with prostate cancer: a cross-sectional study of patient-reported outcomes
- 9 February 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in Japanese Journal of Clinical Oncology
- Vol. 54 (6) , 708-715
Abstract
Objective: To investigate the prevalence of frailty and its effects on cancer-related fatigue and quality of life among patients with prostate cancer. Methods: In this cross-sectional study, questionnaires were administered to 254 outpatients who visited the Department of Urology at Kagawa University Hospital for prostate cancer; finally, 108 outpatients were analyzed. Frailty, cancer-related fatigue and quality of life were assessed using the G8 screening tool, Japanese version of the Brief Fatigue Inventory and Japanese version of the Short Form 8 Health Survey, respectively. We defined frailty based on a score ≤14 points and divided the patients into frailty and no-frailty groups. We also compared the severity of cancer-related fatigue and quality of life between groups. Results: The prevalence of frailty among 108 outpatients was 63%. Older age correlated with frailty severity (P = 0.0007) but not cancer-related fatigue severity (P = 0.2391). The proportion of patients on treatment or with metastasis was not significantly different between groups. The frailty group had higher cancer-related fatigue severity (P = 0.004) and decreased levels of general activity, mood, walking ability, normal work and enjoyment of life, especially on the Brief Fatigue Inventory subscale. The frailty group had lower physical and mental quality of life than the no-frailty group or general population. Conclusions: The frailty rate for these patients increased with age, exceeding 60% regardless of the treatment status, and was associated with worsened cancer-related fatigue severity and reduced quality of life. Our study highlights the importance of assessing frailty when selecting treatment, especially in older patients.Keywords
This publication has 28 references indexed in Scilit:
- Incidence and Correlates of Fatigue in Metastatic Castration-Resistant Prostate Cancer: A Systematic ReviewClinical Genitourinary Cancer, 2016
- Patient‐reported ‘ever had’ and ‘current’ long‐term physical symptoms after prostate cancer treatmentsBJU International, 2015
- Cancer-related fatigue: results from patient experience surveys undertaken in a UK regional cancer centreSupportive Care in Cancer, 2014
- The prevalence and outcomes of frailty in older cancer patients: a systematic reviewAnnals of Oncology, 2014
- Cancer-related fatigue—mechanisms, risk factors, and treatmentsNature Reviews Clinical Oncology, 2014
- Accuracy of the G-8 geriatric-oncology screening tool for identifying vulnerable elderly patients with cancer according to tumour site: The ELCAPA-02 studyJournal of Geriatric Oncology, 2014
- Screening older cancer patients: first evaluation of the G-8 geriatric screening toolAnnals of Oncology, 2012
- Clinically relevant fatigue in men with hormone-sensitive prostate cancer on long-term androgen deprivation therapyAnnals of Oncology, 2011
- Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin–gemcitabine or carboplatin–paclitaxel: NVALT-3 a phase III studyAnnals of Oncology, 2011
- Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric OncologyBJU International, 2010